Bausch Health Companies Inc. (BHC)
USD 7.34
(-4.43%)
USD 7.34
(-4.43%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 27.35 Billion USD | 6.48% |
| 2022 | 25.68 Billion USD | -12.04% |
| 2021 | 29.2 Billion USD | -6.4% |
| 2020 | 31.19 Billion USD | -7.87% |
| 2019 | 33.86 Billion USD | 23.38% |
| 2018 | 27.44 Billion USD | -26.8% |
| 2017 | 37.49 Billion USD | -13.86% |
| 2016 | 43.52 Billion USD | -11.1% |
| 2015 | 48.96 Billion USD | 85.8% |
| 2014 | 26.35 Billion USD | -5.78% |
| 2013 | 27.97 Billion USD | 55.82% |
| 2012 | 17.95 Billion USD | 36.59% |
| 2011 | 13.14 Billion USD | 21.74% |
| 2010 | 10.79 Billion USD | 422.25% |
| 2009 | 2.06 Billion USD | 27.32% |
| 2008 | 1.62 Billion USD | -8.9% |
| 2007 | 1.78 Billion USD | -18.06% |
| 2006 | 2.17 Billion USD | -0.6% |
| 2005 | 2.18 Billion USD | 8.74% |
| 2004 | 2.01 Billion USD | 4.65% |
| 2003 | 1.92 Billion USD | 4.85% |
| 2002 | 1.83 Billion USD | 37.73% |
| 2001 | 1.33 Billion USD | 20.25% |
| 2000 | 1.1 Billion USD | 74.35% |
| 1999 | 635.1 Million USD | 217.71% |
| 1998 | 199.9 Million USD | 113.34% |
| 1997 | 93.7 Million USD | 59.9% |
| 1996 | 58.6 Million USD | -3.78% |
| 1995 | 60.9 Million USD | 137.89% |
| 1994 | 25.6 Million USD | 9.87% |
| 1993 | 23.3 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 26.54 Billion USD | 0.18% |
| 2024 Q2 | 26.49 Billion USD | -1.47% |
| 2024 Q1 | 26.88 Billion USD | -1.7% |
| 2023 Q3 | 27.06 Billion USD | -19.92% |
| 2023 FY | 27.35 Billion USD | 6.48% |
| 2023 Q4 | 27.35 Billion USD | 1.06% |
| 2023 Q2 | 33.79 Billion USD | 32.82% |
| 2023 Q1 | 25.44 Billion USD | -0.94% |
| 2022 Q4 | 25.68 Billion USD | -2.33% |
| 2022 FY | 25.68 Billion USD | -12.04% |
| 2022 Q1 | 29.09 Billion USD | -0.38% |
| 2022 Q2 | 28.17 Billion USD | -3.16% |
| 2022 Q3 | 26.29 Billion USD | -6.65% |
| 2021 Q3 | 29.25 Billion USD | -2.63% |
| 2021 Q1 | 30.19 Billion USD | -3.21% |
| 2021 Q4 | 29.2 Billion USD | -0.17% |
| 2021 Q2 | 30.04 Billion USD | -0.51% |
| 2021 FY | 29.2 Billion USD | -6.4% |
| 2020 Q4 | 31.19 Billion USD | -1.15% |
| 2020 Q3 | 31.56 Billion USD | 0.53% |
| 2020 FY | 31.19 Billion USD | -7.87% |
| 2020 Q1 | 31.86 Billion USD | -5.9% |
| 2020 Q2 | 31.39 Billion USD | -1.47% |
| 2019 Q1 | 32.55 Billion USD | 18.6% |
| 2019 FY | 33.86 Billion USD | 23.38% |
| 2019 Q4 | 33.86 Billion USD | 6.93% |
| 2019 Q3 | 31.66 Billion USD | -2.12% |
| 2019 Q2 | 32.35 Billion USD | -0.61% |
| 2018 Q4 | 27.44 Billion USD | -18.74% |
| 2018 FY | 27.44 Billion USD | -26.8% |
| 2018 Q3 | 33.77 Billion USD | -1.95% |
| 2018 Q2 | 34.44 Billion USD | -3.77% |
| 2018 Q1 | 35.79 Billion USD | -4.53% |
| 2017 Q4 | 37.49 Billion USD | -6.2% |
| 2017 Q3 | 39.97 Billion USD | -4.21% |
| 2017 Q1 | 42.33 Billion USD | -2.75% |
| 2017 FY | 37.49 Billion USD | -13.86% |
| 2017 Q2 | 41.73 Billion USD | -1.42% |
| 2016 Q2 | 47.66 Billion USD | -2.77% |
| 2016 Q1 | 49.01 Billion USD | 0.11% |
| 2016 FY | 43.52 Billion USD | -11.1% |
| 2016 Q3 | 45.76 Billion USD | -3.99% |
| 2016 Q4 | 43.52 Billion USD | -4.88% |
| 2015 Q4 | 48.96 Billion USD | 1.05% |
| 2015 Q2 | 48.34 Billion USD | 25.35% |
| 2015 FY | 48.96 Billion USD | 85.8% |
| 2015 Q1 | 38.56 Billion USD | 46.34% |
| 2015 Q3 | 48.45 Billion USD | 0.23% |
| 2014 FY | 26.35 Billion USD | -5.78% |
| 2014 Q2 | 27.89 Billion USD | -0.33% |
| 2014 Q3 | 27.05 Billion USD | -3.0% |
| 2014 Q4 | 26.35 Billion USD | -2.61% |
| 2014 Q1 | 27.98 Billion USD | 0.07% |
| 2013 Q3 | 28.2 Billion USD | 42.57% |
| 2013 Q4 | 27.97 Billion USD | -0.83% |
| 2013 Q2 | 19.78 Billion USD | 13.13% |
| 2013 Q1 | 17.48 Billion USD | -2.58% |
| 2013 FY | 27.97 Billion USD | 55.82% |
| 2012 FY | 17.95 Billion USD | 36.59% |
| 2012 Q1 | 13.61 Billion USD | 3.64% |
| 2012 Q2 | 14.01 Billion USD | 2.94% |
| 2012 Q3 | 14.14 Billion USD | 0.9% |
| 2012 Q4 | 17.95 Billion USD | 26.89% |
| 2011 FY | 13.14 Billion USD | 21.74% |
| 2011 Q2 | 11.82 Billion USD | 1.2% |
| 2011 Q3 | 11.81 Billion USD | -0.08% |
| 2011 Q4 | 13.14 Billion USD | 11.2% |
| 2011 Q1 | 11.68 Billion USD | 8.27% |
| 2010 Q1 | 2 Billion USD | -3.0% |
| 2010 FY | 10.79 Billion USD | 422.25% |
| 2010 Q3 | 11.13 Billion USD | 448.64% |
| 2010 Q4 | 10.79 Billion USD | -3.06% |
| 2010 Q2 | 2.02 Billion USD | 1.23% |
| 2009 Q3 | 2.02 Billion USD | -1.75% |
| 2009 Q2 | 2.05 Billion USD | 32.21% |
| 2009 Q4 | 2.06 Billion USD | 2.21% |
| 2009 FY | 2.06 Billion USD | 27.32% |
| 2009 Q1 | 1.55 Billion USD | -4.11% |
| 2008 FY | 1.62 Billion USD | -8.9% |
| 2008 Q4 | 1.62 Billion USD | 8.17% |
| 2008 Q3 | 1.5 Billion USD | -8.46% |
| 2008 Q1 | 1.78 Billion USD | 0.43% |
| 2008 Q2 | 1.63 Billion USD | -8.39% |
| 2007 Q2 | 1.75 Billion USD | -19.86% |
| 2007 FY | 1.78 Billion USD | -18.06% |
| 2007 Q3 | 1.71 Billion USD | -2.64% |
| 2007 Q1 | 2.19 Billion USD | 0.87% |
| 2007 Q4 | 1.78 Billion USD | 4.11% |
| 2006 Q2 | 2.11 Billion USD | 2.6% |
| 2006 FY | 2.17 Billion USD | -0.6% |
| 2006 Q1 | 2.05 Billion USD | -5.92% |
| 2006 Q3 | 2.07 Billion USD | -1.82% |
| 2006 Q4 | 2.17 Billion USD | 4.88% |
| 2005 Q3 | 1.91 Billion USD | 5.3% |
| 2005 Q1 | 1.7 Billion USD | -15.33% |
| 2005 Q2 | 1.81 Billion USD | 6.62% |
| 2005 Q4 | 2.18 Billion USD | 14.4% |
| 2005 FY | 2.18 Billion USD | 8.74% |
| 2004 Q4 | 2.01 Billion USD | 13.63% |
| 2004 Q2 | 1.76 Billion USD | -3.01% |
| 2004 Q1 | 1.82 Billion USD | -5.13% |
| 2004 Q3 | 1.77 Billion USD | 0.09% |
| 2004 FY | 2.01 Billion USD | 4.65% |
| 2003 Q4 | 1.92 Billion USD | -5.59% |
| 2003 Q3 | 2.03 Billion USD | 0.3% |
| 2003 Q2 | 2.03 Billion USD | 14.5% |
| 2003 Q1 | 1.77 Billion USD | -3.3% |
| 2003 FY | 1.92 Billion USD | 4.85% |
| 2002 Q4 | 1.83 Billion USD | 10.54% |
| 2002 Q1 | 1.53 Billion USD | 15.63% |
| 2002 Q3 | 1.65 Billion USD | 7.63% |
| 2002 Q2 | 1.54 Billion USD | 0.12% |
| 2002 FY | 1.83 Billion USD | 37.73% |
| 2001 Q4 | 1.33 Billion USD | 28.41% |
| 2001 FY | 1.33 Billion USD | 20.25% |
| 2001 Q1 | 1.02 Billion USD | -7.45% |
| 2001 Q2 | 1.04 Billion USD | 2.19% |
| 2001 Q3 | 1.03 Billion USD | -0.98% |
| 2000 Q2 | 753.68 Million USD | 3.08% |
| 2000 FY | 1.1 Billion USD | 74.35% |
| 2000 Q1 | 731.16 Million USD | 15.13% |
| 2000 Q4 | 1.1 Billion USD | 68.81% |
| 2000 Q3 | 655.9 Million USD | -12.97% |
| 1999 Q2 | 209 Million USD | 2.8% |
| 1999 Q3 | 233.5 Million USD | 11.72% |
| 1999 Q4 | 635.1 Million USD | 171.99% |
| 1999 FY | 635.1 Million USD | 217.71% |
| 1999 Q1 | 203.3 Million USD | 1.7% |
| 1998 Q1 | 124.8 Million USD | 33.19% |
| 1998 Q3 | 119.6 Million USD | -5.23% |
| 1998 Q2 | 126.2 Million USD | 1.12% |
| 1998 FY | 199.9 Million USD | 113.34% |
| 1998 Q4 | 199.9 Million USD | 67.14% |
| 1997 Q1 | 61.2 Million USD | 4.44% |
| 1997 Q4 | 93.7 Million USD | 16.25% |
| 1997 Q3 | 80.6 Million USD | 21.94% |
| 1997 Q2 | 66.1 Million USD | 8.01% |
| 1997 FY | 93.7 Million USD | 59.9% |
| 1996 Q2 | 67.1 Million USD | -1.9% |
| 1996 Q3 | 66.6 Million USD | -0.75% |
| 1996 Q4 | 58.6 Million USD | -12.01% |
| 1996 Q1 | 68.4 Million USD | 12.32% |
| 1996 FY | 58.6 Million USD | -3.78% |
| 1995 Q4 | 60.9 Million USD | 0.4% |
| 1995 FY | 60.9 Million USD | 137.89% |
| 1995 Q3 | 60.65 Million USD | -0.2% |
| 1995 Q1 | 25.2 Million USD | -1.56% |
| 1995 Q2 | 60.77 Million USD | 141.18% |
| 1994 Q4 | 25.6 Million USD | 0.0% |
| 1994 FY | 25.6 Million USD | 9.87% |
| 1993 FY | 23.3 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 3.47 Billion USD | -687.601% |
| Catalent, Inc. | 9.75 Billion USD | -180.427% |
| Emergent BioSolutions Inc. | 1.83 Billion USD | -1390.544% |
| Elanco Animal Health Incorporated | 14.36 Billion USD | -90.433% |
| Perrigo Company plc | 10.8 Billion USD | -153.028% |
| Teva Pharmaceutical Industries Limited | 43.47 Billion USD | 37.096% |
| Zoetis Inc. | 14.28 Billion USD | -91.446% |